Remetinostat
Modify Date: 2024-01-02 18:28:28
Remetinostat structure
|
Common Name | Remetinostat | ||
|---|---|---|---|---|
| CAS Number | 946150-57-8 | Molecular Weight | 323.34100 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H21NO6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RemetinostatRemetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma[1]. |
| Name | methyl 4-[8-(hydroxyamino)-8-oxooctanoyl]oxybenzoate |
|---|---|
| Synonym | More Synonyms |
| Description | Remetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma[1]. |
|---|---|
| Related Catalog | |
| Target |
HDAC[1]. |
| References |
| Molecular Formula | C16H21NO6 |
|---|---|
| Molecular Weight | 323.34100 |
| Exact Mass | 323.13700 |
| PSA | 101.93000 |
| LogP | 2.61550 |
| Storage condition | 2-8℃ |
| Benzoic acid,8-dioxooctyl]oxy]-,methyl ester (MP-shape) |
| Methylparaben suberohydroxamic acid phenyl ester |
| Remetinostat |